Related Experiment Video
Updated: Jan 23, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Association between changes in subcutaneous fat mass and heart failure-induced cachexia: a case report
Takuya Mori1,2,3, Kousuke Oku4,5, Yoshihiro Miyagawa1,2
1Hanna Central Hospital: 741 Tawaraguchi-cho, Ikoma-shi, Nara 630-0243, Japan.
Diagnostic ultrasonography can evaluate changes in subcutaneous fat mass in heart failure patients experiencing cardiac cachexia. This non-invasive method helps track cachexia progression and treatment effectiveness.
Area of Science:
- Cardiology
- Medical Imaging
- Biomedical Engineering
Background:
- Cardiac cachexia is a complex syndrome in heart failure patients, characterized by involuntary weight loss and muscle wasting.
- Subcutaneous fat mass changes are a key indicator of cachexia, but their assessment can be challenging.
- Non-invasive imaging techniques may offer a valuable tool for monitoring these changes.
Purpose of the Study:
- To determine if diagnostic ultrasonography can effectively evaluate changes in subcutaneous fat mass in heart failure patients with cardiac cachexia.
- To assess the utility of ultrasonography in monitoring the progression or improvement of cardiac cachexia.
Main Methods:
- A case study of a heart failure patient with confirmed cardiac cachexia.
- Ultrasonographic measurements of femoral subcutaneous fat mass were taken during the cachectic state and at 1 and 2 months post-assessment.
- Cachexia was confirmed by weight loss, reduced dietary intake, and biochemical markers.
Main Results:
- The study documented an increase in the patient's weight.
- Ultrasonographic imaging confirmed an increase in femoral subcutaneous fat mass.
- These findings correlated with an improvement in cardiac cachexia symptoms.
Conclusions:
- Clinically accessible ultrasonic diagnostic equipment is a useful tool for assessing subcutaneous fat mass.
- Subcutaneous fat mass, as measured by ultrasonography, serves as a reliable indicator of cardiac cachexia severity and treatment response.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management

